Eastwood Bio-Medical Canada Inc.
EWOOF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Market Cap | $114,693 | $112,701 | $104,106 | $104,115 |
| - Cash | $18 | $40 | $21 | $123 |
| + Debt | $62 | $62 | $31 | $23 |
| Enterprise Value | $114,736 | $112,723 | $104,117 | $104,016 |
| Revenue | $868 | $1,300 | $981 | $718 |
| % Growth | -33.2% | 32.5% | 36.6% | – |
| Gross Profit | $548 | $903 | $458 | $180 |
| % Margin | 63.2% | 69.5% | 46.7% | 25% |
| EBITDA | -$411 | -$32 | -$496 | -$746 |
| % Margin | -47.3% | -2.5% | -50.5% | -103.9% |
| Net Income | -$547 | -$150 | -$604 | -$852 |
| % Margin | -63% | -11.5% | -61.5% | -118.7% |
| EPS Diluted | -0.006 | -0.002 | -0.009 | -0.012 |
| % Growth | -185% | 77.3% | 29% | – |
| Operating Cash Flow | -$17 | -$4 | -$116 | -$543 |
| Capital Expenditures | $0 | -$3 | -$6 | $0 |
| Free Cash Flow | -$17 | -$7 | -$122 | -$543 |